Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
915.14B | 929.04B | 853.45B | 761.32B | 741.02B | Gross Profit |
330.86B | 337.44B | 302.39B | 243.45B | 221.93B | EBIT |
141.23B | 147.17B | 132.26B | 93.81B | 69.73B | EBITDA |
202.17B | 201.54B | 177.20B | 139.07B | 116.29B | Net Income Common Stockholders |
102.68B | 109.17B | 97.13B | 70.23B | 47.16B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
347.49B | 332.11B | 366.99B | 302.29B | 307.56B | Total Assets |
1.25T | 1.15T | 1.09T | 965.90B | 921.90B | Total Debt |
30.46B | 272.00M | 241.00M | 545.00M | 90.00M | Net Debt |
-342.27B | -329.69B | -361.81B | -300.34B | -304.83B | Total Liabilities |
266.04B | 250.45B | 272.36B | 249.22B | 231.70B | Stockholders Equity |
984.02B | 902.21B | 821.19B | 715.87B | 689.45B |
Cash Flow | Free Cash Flow | |||
87.75B | 115.78B | 85.53B | 58.59B | 63.84B | Operating Cash Flow |
155.52B | 181.70B | 144.49B | 116.31B | 123.64B | Investing Cash Flow |
-67.93B | -159.91B | -57.59B | -57.54B | -59.99B | Financing Cash Flow |
-90.78B | -57.63B | -36.64B | -68.30B | -51.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $12.56B | 14.12 | 13.37% | 1.31% | 5.20% | 100.48% | |
69 Neutral | $13.97B | 22.02 | 25.53% | 1.82% | -0.61% | 15.06% | |
68 Neutral | $8.79B | 9.71 | 16.16% | 4.23% | 2.78% | 1.50% | |
63 Neutral | $18.76B | 18.05 | 7.19% | 9.37% | -6.53% | -50.08% | |
63 Neutral | $24.64B | 18.67 | 18.47% | 2.52% | -7.67% | -0.58% | |
56 Neutral | $10.11B | 26.30 | 3.71% | 2.58% | -1.27% | 48.34% | |
49 Neutral | $1.95B | -1.21 | -21.28% | 3.72% | 1.18% | -30.47% |